. Author manuscript; available in PMC: 2011 Apr 1.

Published in final edited form as: J Rheumatol. 2010 Mar 1;37(4):870–875. doi: 10.3899/jrheum.090826

Table 2.

Active joint counts at time 0, 6 months, and 12 months.

Time	Group	Joint Count, median (95% CI)	Joint Count, mean (SD)	p
0	High dose	5 (4, 5)	7.44 (7.73)	0.0009^*
	Low dose	7.5 (5.02, 11.98)	10.31 (8.31)
6 months	High dose	0 (0)	1.77 (4.45)	0.06^*
	Low dose	2 (1, 2)	2.89 (3.64)
12 months	High dose	0 (0, 0)	1.35 (3.74)	0.08^*
	Low dose	0 (0, 1)	1.36 (2.39)

Wilcoxon rank-sum analysis comparing median active joint counts between the 2 groups at time 0 (start of MTX), 6 months, and 12 months.